For example, Hemmatazad et al. indicated that CCR5 is a potential therapeutic target for cancer and its higher expression is associated with poor outcomes in various malignancies and cells expressing CCR5 modulate the immune response and tumor progression21. This evidence concerns the gene CCR5 and neoplasm.